<scp>DKK1</scp> drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with <scp>anti‐DKK1</scp> therapeutic <scp>DKN</scp> ‐01
Edward J. Jarman(Western General Hospital), Luke Boulter(MRC Institute of Genetics and Molecular Medicine), Stephanie MacMaster(Institute of Genetics and Cancer), David H. Wilson(University of Zimbabwe), Konstantinos Gournopanos(Institute of Genetics and Cancer), Michael H. Kagey, Panagiota Tsokkou(Institute of Genetics and Cancer), Marta Horcas‐Lopez(MRC Centre for Reproductive Health), Jeffrey W. Pollard(Albert Einstein College of Medicine), Scott H. Waddell(Edinburgh Cancer Research), William Cambridge(Institute of Genetics and Cancer), Walter Newman(Ensemble Therapeutics (United States)), Minn E Ng(Institute of Genetics and Cancer), Kamila Irena Musialik(Institute of Genetics and Cancer), Daniel Soong(MRC Centre for Reproductive Health)
Cited by 20
Related Papers
Microenvironmental regulation of metastasis
|Nature reviews. Cancer|2008|3.7k
Immune cell promotion of metastasis
|Nature reviews. Immunology|2015|1.2k
Trophic macrophages in development and disease
|Nature reviews. Immunology|2009|1.2k
Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
|Cancer Cell|2019|948
Genomic Profiling of MicroRNAs and Messenger RNAs Reveals Hormonal Regulation in MicroRNA Expression in Human Endometrium1
|Biology of Reproduction|2009|288